Skip to main content
Top
Published in: Clinical Rheumatology 1/2015

Open Access 01-03-2015 | Review Article

Burden of illness of rheumatoid arthritis in Latin America: a regional perspective

Authors: L. A. Ramírez, C. Rodríguez, M. H. Cardiel

Published in: Clinical Rheumatology | Special Issue 1/2015

Login to get access

Abstract

Rheumatoid arthritis (RA) is one of the most important rheumatic diseases. Its prevalence varies among ethnic groups. Genetic and environmental factors influence its incidence and prevalence. This chronic disease will increase its frequency in the future due to population aging. The personal impact of this disease on many relevant areas of an individual requires special efforts to prevent and treat it properly. Adequate advice on several recently described risk factors such as tobacco and alcohol exposure, infections, obesity, and physical exercise should be part of every medical consultation. This knowledge should be incorporated to improve health care prevention programs. Patients and clinicians must work together through better communication skills to finally improve outcomes. Including RA in priority health care lists will need special effort from rheumatology societies and better communication with policy makers.
Footnotes
1
Let us help! is inspired by David deBronkart’s quote “Please, let patients help improve healthcare. Let patients help steer our decisions, strategic and practical. Let patients help define what value in medicine is.”
 
Literature
2.
3.
go back to reference Scublinsky D, Venarotti H, Citera G, Messina OD, Scheines E, Rillo O et al (2010) The prevalence of rheumatoid arthritis in Argentina: a capture-recapture study in a city in Buenos Aires province. J Clin Rheumatol 16:317–321. doi:10.1097/RHU.0b013e3181f3bfdd PubMed Scublinsky D, Venarotti H, Citera G, Messina OD, Scheines E, Rillo O et al (2010) The prevalence of rheumatoid arthritis in Argentina: a capture-recapture study in a city in Buenos Aires province. J Clin Rheumatol 16:317–321. doi:10.​1097/​RHU.​0b013e3181f3bfdd​ PubMed
4.
go back to reference Quintana R, Silvestre A, Goñi M et al (2013) “Prevalencia de malestares músculo-esqueléticos y enfermedades reumáticas en población originaria qom (toba) de la ciudad de rosario”, comunicacion oral. 46 Congreso Argentino de Reumatología, Mar del Plata Quintana R, Silvestre A, Goñi M et al (2013) “Prevalencia de malestares músculo-esqueléticos y enfermedades reumáticas en población originaria qom (toba) de la ciudad de rosario”, comunicacion oral. 46 Congreso Argentino de Reumatología, Mar del Plata
6.
go back to reference Del Rincón I, Battafarano ID, Arroyo RA et al (2003) Ethnic variation in the clinical manifestation of rheumatoid arthritis: role of HLA-DRB1 alleles. Arthritis Rheum 49:200–208CrossRefPubMed Del Rincón I, Battafarano ID, Arroyo RA et al (2003) Ethnic variation in the clinical manifestation of rheumatoid arthritis: role of HLA-DRB1 alleles. Arthritis Rheum 49:200–208CrossRefPubMed
7.
go back to reference Morgan AW, Thomson W, Martin SG et al (2009) Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22 and smoking in determining susceptibility to autoantibody positive and autoantibody negative rheumatoid arthritis in a large UK Caucasian population. Arthritis Rheum 60:2565–2576. doi:10.1002/art.24752 CrossRefPubMed Morgan AW, Thomson W, Martin SG et al (2009) Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22 and smoking in determining susceptibility to autoantibody positive and autoantibody negative rheumatoid arthritis in a large UK Caucasian population. Arthritis Rheum 60:2565–2576. doi:10.​1002/​art.​24752 CrossRefPubMed
8.
go back to reference Lo SF, Huang CM, Lin HC et al (2005) Association of CYP17 gene polymorphism and rheumatoid arthritis in Chinese patients in central Taiwan. Rheumatol Int 25:580–584CrossRefPubMed Lo SF, Huang CM, Lin HC et al (2005) Association of CYP17 gene polymorphism and rheumatoid arthritis in Chinese patients in central Taiwan. Rheumatol Int 25:580–584CrossRefPubMed
9.
go back to reference Herráez DL, Martínez-Bueno M, Riba L et al (2013) Rheumatoid arthritis in Latin Americans enriched for Amerindian ancestry is associated with loci in chromosomes 1, 12, and 13, and the HLA Class II region. Arthritis Rheum 65:1457–1467. doi:10.1002/art.37923 CrossRef Herráez DL, Martínez-Bueno M, Riba L et al (2013) Rheumatoid arthritis in Latin Americans enriched for Amerindian ancestry is associated with loci in chromosomes 1, 12, and 13, and the HLA Class II region. Arthritis Rheum 65:1457–1467. doi:10.​1002/​art.​37923 CrossRef
12.
go back to reference Lu B, Solomon DH, Costenbader KH et al (2014) Alcohol consumption and risk of incident rheumatoid arthritis in women. A prospective study. Arthritis Rheum 66:1998–2005. doi:10.1002/art.38634 CrossRef Lu B, Solomon DH, Costenbader KH et al (2014) Alcohol consumption and risk of incident rheumatoid arthritis in women. A prospective study. Arthritis Rheum 66:1998–2005. doi:10.​1002/​art.​38634 CrossRef
15.
go back to reference Al-Katma MK, Bisada NF, Bordeaux JM et al (2007) Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheumatol 13:134–137CrossRefPubMed Al-Katma MK, Bisada NF, Bordeaux JM et al (2007) Control of periodontal infection reduces the severity of active rheumatoid arthritis. J Clin Rheumatol 13:134–137CrossRefPubMed
17.
go back to reference Parks CG, Wallit BT, Pettinger M et al (2011) Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women’s Health Initiative Observational Study. Arthritis Care Res 63:184–194. doi:10.1002/acr.20335 CrossRef Parks CG, Wallit BT, Pettinger M et al (2011) Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women’s Health Initiative Observational Study. Arthritis Care Res 63:184–194. doi:10.​1002/​acr.​20335 CrossRef
18.
go back to reference Pedersen M, Jacobsen S, Klarlund M et al (2006) Socioeconomic status and risk of rheumatoid arthritis: a Danish case–control study. J Rheumatol 233:1069–1074 Pedersen M, Jacobsen S, Klarlund M et al (2006) Socioeconomic status and risk of rheumatoid arthritis: a Danish case–control study. J Rheumatol 233:1069–1074
19.
go back to reference Crowson CS, Matteson EL, Davis JM 3rd et al (2013) Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care Res 65:71–77. doi:10.1002/acr.21660 CrossRef Crowson CS, Matteson EL, Davis JM 3rd et al (2013) Contribution of obesity to the rise in incidence of rheumatoid arthritis. Arthritis Care Res 65:71–77. doi:10.​1002/​acr.​21660 CrossRef
23.
go back to reference Lidgren L (2003) The bone and joint decade and the global economic and health care burden of musculoskeletal disease. J Rheumatol 30(Suppl 67):4–5 Lidgren L (2003) The bone and joint decade and the global economic and health care burden of musculoskeletal disease. J Rheumatol 30(Suppl 67):4–5
24.
go back to reference Yelin E (2013) Economic burden of rheumatic diseases. In: Firestein GS, Budd R, Gabriel SE (eds) Kelly’s textbook of rheumatology, 9th edn. Elsevier, Philadelphia, pp 440–451CrossRef Yelin E (2013) Economic burden of rheumatic diseases. In: Firestein GS, Budd R, Gabriel SE (eds) Kelly’s textbook of rheumatology, 9th edn. Elsevier, Philadelphia, pp 440–451CrossRef
25.
go back to reference Newhall-perry K, Law NJ, Ramos R et al (2000) Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. J Rheumatol 27:1156–1163PubMed Newhall-perry K, Law NJ, Ramos R et al (2000) Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. J Rheumatol 27:1156–1163PubMed
26.
go back to reference Michaud K, Messer J, Choi HK, Wolfe F (2003) Direct medical costs and their predictors in patients with rheumatoid arthritis. A three-year study of 7,527 patients. Arthritis Rheum 48:2750–2762CrossRefPubMed Michaud K, Messer J, Choi HK, Wolfe F (2003) Direct medical costs and their predictors in patients with rheumatoid arthritis. A three-year study of 7,527 patients. Arthritis Rheum 48:2750–2762CrossRefPubMed
27.
go back to reference Chevreol K, Haour G, Lucier S et al. (2014) Evolution of direct costs in the first years of rheumatoid arthritis: impact of early versus late biologic initiation an economic analysis based on ESPOIR cohort. PLoS One:9 DOI: 10.137/journal.pone.0097077 Chevreol K, Haour G, Lucier S et al. (2014) Evolution of direct costs in the first years of rheumatoid arthritis: impact of early versus late biologic initiation an economic analysis based on ESPOIR cohort. PLoS One:9 DOI: 10.137/journal.pone.0097077
28.
go back to reference Ziegler S, Huscher D, Karberg K et al (2010) Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997–2007: results from the national database of the German collaborative arthritis centres. Ann Rheum Dis 69:1803–1808. doi:10.1136/ard.2009.122101 CrossRefPubMed Ziegler S, Huscher D, Karberg K et al (2010) Trends in treatment and outcomes of rheumatoid arthritis in Germany 1997–2007: results from the national database of the German collaborative arthritis centres. Ann Rheum Dis 69:1803–1808. doi:10.​1136/​ard.​2009.​122101 CrossRefPubMed
29.
go back to reference ter Wee MM, Lems WF, Usan H et al (2012) The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review. Ann Rheum Dis 71:161–171. doi:10.1136/ard.2011.154583 PubMed ter Wee MM, Lems WF, Usan H et al (2012) The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review. Ann Rheum Dis 71:161–171. doi:10.​1136/​ard.​2011.​154583 PubMed
30.
31.
go back to reference Lajas C, Abasolo L, Bellajdel B et al (2003) Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. Arthritis Rheum 49:64–70CrossRefPubMed Lajas C, Abasolo L, Bellajdel B et al (2003) Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study. Arthritis Rheum 49:64–70CrossRefPubMed
32.
go back to reference Merhesdal S, Ruof J, Schöffski O et al (2001) Indirect medical costs in early rheumatoid arthritis. Composition of and changes in indirect costs within first three years of disease. Arthritis Rheum 44:528–534CrossRef Merhesdal S, Ruof J, Schöffski O et al (2001) Indirect medical costs in early rheumatoid arthritis. Composition of and changes in indirect costs within first three years of disease. Arthritis Rheum 44:528–534CrossRef
33.
go back to reference Hernández-Cruz B, Ariza-Ariza R, Cardiel-Rios MH (2006) Costs of the standard rheumatology care in active Rheumatoid arthritis patients seen in a tertiary care center in Mexico city. Reum Clin 2:124–130CrossRef Hernández-Cruz B, Ariza-Ariza R, Cardiel-Rios MH (2006) Costs of the standard rheumatology care in active Rheumatoid arthritis patients seen in a tertiary care center in Mexico city. Reum Clin 2:124–130CrossRef
34.
35.
go back to reference Mora C, González A, Diaz J, Quintana G (2009) Costos directos de la artritis reumatoide temprana en el primer año de atención: simulación de tres situaciones clínicas en un hospital universitario de tercer nivel en Colombia. Biomedica 29:43–50CrossRefPubMed Mora C, González A, Diaz J, Quintana G (2009) Costos directos de la artritis reumatoide temprana en el primer año de atención: simulación de tres situaciones clínicas en un hospital universitario de tercer nivel en Colombia. Biomedica 29:43–50CrossRefPubMed
36.
go back to reference Baron (1981) In: Gerteis M, Edgman-Levitan S, Daley J, Delbanco T 1993 (eds) 21 Baron (1981) In: Gerteis M, Edgman-Levitan S, Daley J, Delbanco T 1993 (eds) 21
37.
go back to reference Coulter A The expert patient: a new approach to chronic disease management for the 21st century, Department of Health NHS 11 Coulter A The expert patient: a new approach to chronic disease management for the 21st century, Department of Health NHS 11
Metadata
Title
Burden of illness of rheumatoid arthritis in Latin America: a regional perspective
Authors
L. A. Ramírez
C. Rodríguez
M. H. Cardiel
Publication date
01-03-2015
Publisher
Springer London
Published in
Clinical Rheumatology / Issue Special Issue 1/2015
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-3012-0

Other articles of this Special Issue 1/2015

Clinical Rheumatology 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.